317 related articles for article (PubMed ID: 37233460)
21. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
[TBL] [Abstract][Full Text] [Related]
22. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
23. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
24. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery.
Terracciano M; Shahbazi MA; Correia A; Rea I; Lamberti A; De Stefano L; Santos HA
Nanoscale; 2015 Dec; 7(47):20063-74. PubMed ID: 26568517
[TBL] [Abstract][Full Text] [Related]
25. Diatom Silica for Biomedical Applications: Recent Progress and Advances.
Maher S; Kumeria T; Aw MS; Losic D
Adv Healthc Mater; 2018 Oct; 7(19):e1800552. PubMed ID: 30118185
[TBL] [Abstract][Full Text] [Related]
26. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
[TBL] [Abstract][Full Text] [Related]
27. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
28. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
29. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
[TBL] [Abstract][Full Text] [Related]
30. Horizons of nanotechnology applications in female specific cancers.
Rajitha B; Malla RR; Vadde R; Kasa P; Prasad GLV; Farran B; Kumari S; Pavitra E; Kamal MA; Raju GSR; Peela S; Nagaraju GP
Semin Cancer Biol; 2021 Feb; 69():376-390. PubMed ID: 31301361
[TBL] [Abstract][Full Text] [Related]
31. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.
Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
[TBL] [Abstract][Full Text] [Related]
32. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art.
El-Zahaby SA; Elnaggar YSR; Abdallah OY
J Control Release; 2019 Jan; 293():21-35. PubMed ID: 30445002
[TBL] [Abstract][Full Text] [Related]
33. Critical considerations for targeting colorectal liver metastases with nanotechnology.
Arshad U; Sutton PA; Ashford MB; Treacher KE; Liptrott NJ; Rannard SP; Goldring CE; Owen A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1588. PubMed ID: 31566913
[TBL] [Abstract][Full Text] [Related]
34. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
Phillips MC; Mousa SA
Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
[TBL] [Abstract][Full Text] [Related]
35. Diatoms with Invaluable Applications in Nanotechnology, Biotechnology, and Biomedicine: Recent Advances.
Rabiee N; Khatami M; Jamalipour Soufi G; Fatahi Y; Iravani S; Varma RS
ACS Biomater Sci Eng; 2021 Jul; 7(7):3053-3068. PubMed ID: 34152742
[TBL] [Abstract][Full Text] [Related]
36. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers.
Yang J; Wang X; Wang B; Park K; Wooley K; Zhang S
Adv Drug Deliv Rev; 2022 Nov; 190():114525. PubMed ID: 36100142
[TBL] [Abstract][Full Text] [Related]
37. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management.
Tagde P; Najda A; Nagpal K; Kulkarni GT; Shah M; Ullah O; Balant S; Rahman MH
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269998
[TBL] [Abstract][Full Text] [Related]
38. Targeted drug delivery using genetically engineered diatom biosilica.
Delalat B; Sheppard VC; Rasi Ghaemi S; Rao S; Prestidge CA; McPhee G; Rogers ML; Donoghue JF; Pillay V; Johns TG; Kröger N; Voelcker NH
Nat Commun; 2015 Nov; 6():8791. PubMed ID: 26556723
[TBL] [Abstract][Full Text] [Related]
39. Preparation of biosilica structures from frustules of diatoms and their applications: current state and perspectives.
Wang Y; Cai J; Jiang Y; Jiang X; Zhang D
Appl Microbiol Biotechnol; 2013 Jan; 97(2):453-60. PubMed ID: 23179621
[TBL] [Abstract][Full Text] [Related]
40. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.
Rodríguez F; Caruana P; De la Fuente N; Español P; Gámez M; Balart J; Llurba E; Rovira R; Ruiz R; Martín-Lorente C; Corchero JL; Céspedes MV
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
